OncoTherapy Science, Inc.

OncoTherapy Science, Inc. - PE Ratioverified

4564.T

Price:

$19

Market Cap:

$7.57B

OncoTherapy Science, Inc. engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan. Its development pipeline includes OTS167, a small molecular compound that targets the maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a small molecule TOPK inhibitor currently under non-clinical stage. The company’s pipeline also comprises cancer peptide vaccines, including S-588410, which completed Phase III clinical trials for the treatment esop...[Read more]

Industry

Biotechnology

IPO Date

2005-09-29

Stock Exchange

JPX

Ticker

4564.T

The PE Ratio as of October 2026 (TTM) for OncoTherapy Science, Inc. (4564.T) is -8.05

According to OncoTherapy Science, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.05. This represents a change of -26.38% compared to the average of -10.93 of the last 4 quarters.

OncoTherapy Science, Inc. (4564.T) Historical PE Ratio (quarterly & annually)

How has 4564.T PE Ratio performed in the past?

The mean historical PE Ratio of OncoTherapy Science, Inc. over the last ten years is -8.11. The current -8.05 PE Ratio has changed 9.82% with respect to the historical average. Over the past ten years (40 quarters), 4564.T's PE Ratio was at its highest in in the March 2024 quarter at -3.62. The PE Ratio was at its lowest in in the March 2026 quarter at -21.00.

Quarterly (TTM)
Annual

Average

-8.11

Median

-7.84

Minimum

-13.88

Maximum

-3.31

OncoTherapy Science, Inc. (4564.T) PE Ratio by Quarter and Year

Discovering the peaks and valleys of OncoTherapy Science, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 207.43%

Maximum Annual PE Ratio = -3.31

Minimum Annual Increase = -63.77%

Minimum Annual PE Ratio = -13.88

Quarterly (TTM)
Annual
YearPE RatioChange
2026-7.58-15.52%
2025-8.97171.47%
2024-3.31-59.13%
2023-8.0960.85%
2022-5.03-63.77%
2021-13.88207.43%
2020-4.52-32.94%
2019-6.73-38.99%
2018-11.04-8.01%
2017-12.00-28.65%

OncoTherapy Science, Inc. (4564.T) Average PE Ratio

How has 4564.T PE Ratio performed in the past?

The current PE Ratio of OncoTherapy Science, Inc. (4564.T) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.62

5-year avg

-6.60

10-year avg

-8.11

OncoTherapy Science, Inc. (4564.T) PE Ratio vs. Peers

How is 4564.T’s PE Ratio compared to its peers?

OncoTherapy Science, Inc.’s PE Ratio is greater than K Pharma,Inc. (-8.40), less than BrightPath Biotherapeutics Co., Ltd. (-3.52), greater than ADR120S, Inc. (-12.27), less than Noile-Immune Biotech Inc. (-5.86), less than TMS Co., Ltd. (-6.16), less than Linical Co., Ltd. (-1.19), less than Chiome Bioscience Inc. (-7.17), less than MedRx Co., Ltd (-4.08), less than Kohjin Bio Co., Ltd. (32.85), less than Delta-Fly Pharma, Inc. (-0.73),

Build a custom stock screener for OncoTherapy Science, Inc. (4564.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoTherapy Science, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OncoTherapy Science, Inc. (4564.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OncoTherapy Science, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is OncoTherapy Science, Inc.'s PE Ratio?

How is the PE Ratio calculated for OncoTherapy Science, Inc. (4564.T)?

What is the highest PE Ratio for OncoTherapy Science, Inc. (4564.T)?

What is the 3-year average PE Ratio for OncoTherapy Science, Inc. (4564.T)?

What is the 5-year average PE Ratio for OncoTherapy Science, Inc. (4564.T)?

How does the current PE Ratio for OncoTherapy Science, Inc. (4564.T) compare to its historical average?